Prohost Biotech – Exclusive Biotech Research

Exclusive Market Insight

& Scientific analysis

  • Exclusive Posts
  • Industry Newsletters
  • Clinical Trials
  • Possible Takeovers
  • Technology of the Week
  • Stock Table
  • Therapeutic Vaccines
  • Development-Stage Firms
  • Genomics
  • Prohost Picks
  • And much more...
Menu
  • Impacting News
  • News & Comments
  • Today’s Highlights
  • Trick or Trade
  • Prohost Letters
  • Login / Register
    • Login
    • Register
  • Contact Us
  • Impacting News
  • News & Comments
  • Today’s Highlights
  • Trick or Trade
  • Prohost Letters
  • Login / Register
    • Login
    • Register
  • Contact Us

An Important Reminder from Vir Biotechnology

May 19, 2022 0
Vir Biotechnology  Vir Biotechnology (VIR) is a commercial-stage immunology firm focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir assembled four technology platforms that stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Vir’s current pipeline consists of product candidates targeting COVID-19, hepatitis B and hepatitis D viruses, influenza …

Eisai and Biogen: Lecanemab for the Treament of Early Alzheimer’s...

Sunshine Biopharma’s New mRNA Therapeutics Killed Cancer Cells with Little...

Reata Pharmaceuticals Completed Rolling NDA Submission of Omaveloxolone for Friedreich’s...

Intellia Therapeutics Statement on Recent U.S. Patent and Trademark Office...

These Dangerous World Circumstances and the Prohost Portfolio

The FDA Authorized Emergency Use of Pfizer Paxlovid Pills Against...

The FDA Cleared the IND for Erasca Inc Product ERAS-801...

Takeda Pharmaceutical Product LIVTENCITY Granted Approval by the FDA

Intellia Therapeutics to Highlight Ex Vivo Genome Editing and CRISPR/Cas9...

No Evidence of Data Manipulation in Technical Paper Foundational to...

Gilead Sciences and Merck Initiate Phase 2 Study Evaluating Lenacapavir...

Reata Pharmaceuticals Announces Presentations Highlighting Clinical Data for Bardoxolone and...

The U.S. FDA Approved Oyster Point Pharma Inc Product TYRVAYA™ to...

Don’t Miss the Enanta Pharmaceuticals Virtual Conference on October 19th...

Can Excision BioTherapeutics Inc Cure HIV?!

Can-Fite Biopharma Has Encouraging News but Will It Enthuse Investors?

Cassava Statement Regarding Plasma p-tau Analysis from a Previously Disclosed...

Agenus Good News: Balstilimab Monotherapy Data Published in Gynecologic Oncology

The US FDA Granted Fast Track Designation for Sutro Biopharma...

Impacting News

Exelixis First Quarter 2022 Financial Results. See Also: Milestones in Clinical and Pipeline Development

May 19, 2022 0
Exelixis Press Release This press release covers a large part of Exelixis accomplishments, including important details …

Positive News for Two Undervalued Firms in the Prohost Portfolio

May 5, 2022 0
Exelixis CABOMETYX Approval Exelixis (EXEL) partner Ipsen received approval from the European Commission (EC) for CABOMETYX® (cabozantinib) as a …

Interesting News from PTC Therapeutics and Arcturus Therapeutics Holdings

April 20, 2022 0
Arcturus Therapeutics Holdings News Arcturus Therapeutics Holdings (ARCT) shared topline data from an ongoing Phase 1/2/3 …

Gilead Sciences: The FDA Lifts Partial Clinical Hold on MDS and AML Magrolimab Studies. See Also: BioNTech

April 13, 2022 0
FDA Lifts Partial Clinical Hold on Gilead Sciences Studies of Magrolimab On April 12, 2022, Gilead …

News From Vertex and Cassava: Two Prohost Portfolio Selected Biotech Firms 

March 31, 2022 0
Vertex Pharmaceuticals Statistically Significant Results From Vertex VX-548 for Acute Pain Vertex Pharmaceuticals (VRTX) announced positive …

What Happens to Intellia When the U.S. Patent and Trademark Office Changes Previous Patent Decisions?

March 1, 2022 0
Intellia Therapeutics Loses Technology Patent and Suffers a Selloff A selloff of Intellia Therapeutics (NTLA) stock …

Trick or Trade

What’s Going on with the Clinical-Stage Biotech Firms. See Also: Promising News From Evotec SE

April 9, 2022 0
The Clinical Stage Biotech Firms   We have reasons to believe that some clinical-stage biotechnology firms, …

Our Most Pressing Need. See Also: Important, Recent News from Incyte & Eli Lilly and Halozyme

March 29, 2022 0
Our Most Pressing Need Our current, most pressing need is news that makes sense. Stock Market …

Our Plan as the Stock Market Continues to Plummet

February 17, 2022 2
The Stock Market Continues to Plummet Indeed, the Stock Market continues to decline, losing investors' profits. …

Devastated and Resurrected Good Biotech Firms: Theravance Biopharma

December 15, 2021 0
The Market Devastation and Resurrection of Good Biotech Firms Due to the market’s instability that we …

Agenus Strategic Decision to Withdraw the BLA for Balsitilimab

October 22, 2021 0
Agenus to Withdraw BLA for Balstilimab Agenus (AGEN) announced a strategic decision to withdraw its Biologics …

The Time Has Come to Present Mirum Pharmaceuticals Inc

September 27, 2021 0
Mirum Pharmaceuticals Inc Mirum Pharmaceuticals Inc (MIRM) is a clinical-stage biopharmaceutical company focused on the development …

Today’s Highlights

Karyopharm Therapeutics: CHMP Recommended Approval of the Firm’s Product NEXPOVIO® for Multiple Melanoma in Europe.

May 20, 2022 0
Karyopharm Therapeutics  Karyopharm Therapeutics (KPTI) and the Menarini Group ("Menarini"), a privately-held, leading international pharmaceutical company, announced …

Vertex Provided Successful Results of VX-880 for Type 1 Diabetes Then Placed the Product on Clinical Hold

May 2, 2022 0
A lot is happening while the Stock Market is tanking and is finally being considered a …

Amgen: Repatha Studies Showed Sustained Reduction in Low-Density Lipoprotein Cholesterol with No New Safety Findings

April 27, 2022 0
Amgen Repatha Studies Repatha is the Longest Studied PCSK9i Amgen (AMGN) announced top-line results from two …

Gilead Sciences: Remdesivir is the First and Only Approved Treatment for Pediatric Patients with COVID-19. See Also: Cassava Sciences

April 26, 2022 0
Gilead Sciences Receives sNDA from the FDA for Remdesivir for Pediatric Patients with COVID-19 Gilead Sciences …

Promising Agreement Between Jazz Pharmaceuticals and Werewolf Therapeutics

April 8, 2022 0
Jazz Pharmaceuticals and Werewolf Therapeutics Agreement Jazz Pharmaceuticals (JAZZ) and Werewolf Therapeutics (HOWL)

Gilead Sciences: The FDA Approved Yescarta® – The First CAR T-Cell Therapy for Initial Treatment of Relapsed or Refractory LBCL

April 4, 2022 0
Gilead Sciences' Product Yescarta Kite - a Gilead Sciences (GILD) Company, announced the U.S. FDA has approved …

Prohost Letters

Bear Market. Bad Market. Unpredictable Market.

May 17, 2022 0
Prohost Comprehensive Letter #450 BEAR MARKET. BAD MARKET. UNPREDICTABLE MARKET. Stock market investors usually learn from …

Comprehensive Prohost Letter #449 – Reality

March 27, 2022 0
Comprehensive Prohost Letter Issues Reality The Best of words in informative texts are the smallest in …

Comprehensive Prohost Letter #448

December 22, 2021 0
Comprehensive Prohost Letter Issues Coronavirus Variant Omicron A lot has happened since the coronavirus variant Omicron …

Comprehensive Prohost Letter Issues

September 19, 2021 0
The Comprehensive Prohost Letter Issues The Comprehensive Prohost Letter Issues will constitute a chain of 7 …

A Reevaluation of Prohost Biotech’s Picked Firms

August 9, 2021 0
Prohost Letter #446 A Reevaluation of Prohost Biotech’s Picked Firms We have already pinpointed some of …

Companies Behind the Biotechnology Revolution

July 12, 2021 0
Prohost Portfolio PLUS #7 Companies Behind The Biotechnology Revolution Without these firms, basic science discoveries in …

Search ProhostBiotech

Popular Links

Aerie Pharmaceuticals (AERI) Agenus (AGEN) Alnylam (ALNY) Amgen (AMGN) Array BioPharma (ARRY) AstraZeneca Plc (AZN) Bellicum Pharmaceuticals Inc (BLCM) Bristol-Myers Squibb (BMY) Celgene (CELG) Celldex Therapeutics (CLDX) Cellectis (CLLS) Celyad (CYAD) Compugen (CGEN) CRISPR Therapeutics (CRSP) Editas Medicine Inc (EDIT) Enanta Pharmaceuticals (ENTA) Exelixis (EXEL) Gilead Sciences (GILD) Halozyme Therapeutics (HALO) Illumina (ILMN) ImmunoGen (IMGN) Incyte (INCY) Innoviva (INVA) Intellia Therapeutics (NTLA) Ionis Pharmaceuticals Inc (IONS) Karyopharm Therapeutics Inc (KPTI) Merck (MRK) Moderna Inc (MRNA) Nektar Therapeutics (NKTR) Novartis (NVS) Portola Pharmaceuticals Inc (PTLA) PTC Therapeutics (PTCT) Regeneron Pharmaceuticals (REGN) Regenxbio (RGNX) Rhythm Pharmaceuticals Inc (RYTM) Sangamo Therapeutics Inc (SGMO) Sarepta Therapeutics (SRPT) Seagen Inc (SGEN) Spark Therapeutics Theravance Biopharma (TBPH) Vertex Pharmaceuticals (VRTX) Xoma (XOMA)
  • Recent

ProhostBiotech Archive

Sign Up for Weekly Emails

Prohost Biotech – Exclusive Biotech Research Copyright © 2022.
© 2014 Prohost Biotech. All rights reserved.

Privacy Policy | Cancellation Policy | Forward Looking Statement